Literature DB >> 20339017

Identification of novel pneumolysin alleles from paediatric carriage isolates of Streptococcus pneumoniae.

J M C Jefferies1,2, A S Tocheva2, H Rubery3, J Bennett3, J Garland3, M Christodoulides2, S N Faust3,2, A Smith4, T J Mitchell5, S C Clarke6,2.   

Abstract

Pneumolysin (Ply) is a major virulence factor of Streptococcus pneumoniae and is produced by all known clinical isolates of pneumococci. Pneumolysin toxoids are being considered as vaccine candidates. We investigated the diversity of pneumolysin among 194 nasopharyngeal pneumococci characterized by serotyping and multilocus sequence typing (MLST). Eight Ply protein alleles were identified, four of which were novel. The 4 novel alleles varied at 10 different amino acid positions, from a total of 147, 3 of these substitutions have been previously reported in different combinations. The protein allele correlated closely with MLST. It is critical that the presence of pneumolysin variants is considered with regards to the potential use of Ply in future vaccine formulations, as variation in Ply amino acid sequence may influence the immunogenicity of vaccines based on the presence of an individual Ply allele.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20339017     DOI: 10.1099/jmm.0.018663-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.

Authors:  Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

2.  Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.

Authors:  Philippe Hermand; Annick Vandercammen; Emmanuel Mertens; Emmanuel Di Paolo; Vincent Verlant; Philippe Denoël; Fabrice Godfroid
Journal:  Hum Vaccin Immunother       Date:  2016-10-21       Impact factor: 3.452

3.  Immunodominance in T cell responses elicited against different domains of detoxified pneumolysin PlyD1.

Authors:  Els van Westen; Martien C M Poelen; Germie P J M van den Dobbelsteen; Eliud O Oloo; Martina M Ochs; Nynke Y Rots; Cecile A C M van Els
Journal:  PLoS One       Date:  2018-03-06       Impact factor: 3.240

Review 4.  Impact of Bacterial Toxins in the Lungs.

Authors:  Rudolf Lucas; Yalda Hadizamani; Joyce Gonzales; Boris Gorshkov; Thomas Bodmer; Yves Berthiaume; Ueli Moehrlen; Hartmut Lode; Hanno Huwer; Martina Hudel; Mobarak Abu Mraheil; Haroldo Alfredo Flores Toque; Trinad Chakraborty; Jürg Hamacher
Journal:  Toxins (Basel)       Date:  2020-04-02       Impact factor: 4.546

5.  Diversity of Pneumolysin and Pneumococcal Histidine Triad Protein D of Streptococcus pneumoniae Isolated from Invasive Diseases in Korean Children.

Authors:  Ki Wook Yun; Hyunju Lee; Eun Hwa Choi; Hoan Jong Lee
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

6.  Insights into the Evolutionary Relationships of LytA Autolysin and Ply Pneumolysin-Like Genes in Streptococcus pneumoniae and Related Streptococci.

Authors:  María Morales; Antonio J Martín-Galiano; Mirian Domenech; Ernesto García
Journal:  Genome Biol Evol       Date:  2015-09-08       Impact factor: 3.416

7.  Assessing the function of pneumococcal neuraminidases NanA, NanB and NanC in in vitro and in vivo lung infection models using monoclonal antibodies.

Authors:  Philipp Janesch; Harald Rouha; Adriana Badarau; Lukas Stulik; Irina Mirkina; Marisa Caccamo; Katharina Havlicek; Barbara Maierhofer; Susanne Weber; Karin Groß; Jacqueline Steinhäuser; Manuel Zerbs; Cecilia Varga; Ivana Dolezilkova; Sabine Maier; Gerhild Zauner; Nels Nielson; Christine A Power; Eszter Nagy
Journal:  Virulence       Date:  2018       Impact factor: 5.882

8.  Hypervirulent pneumococcal serotype 1 harbours two pneumolysin variants with differential haemolytic activity.

Authors:  Stavros Panagiotou; Chrispin Chaguza; Reham Yahya; Teerawit Audshasai; Murielle Baltazar; Lorenzo Ressel; Shadia Khandaker; Mansoor Alsahag; Tim J Mitchell; Marc Prudhomme; Aras Kadioglu; Marie Yang
Journal:  Sci Rep       Date:  2020-10-14       Impact factor: 4.379

9.  Structural insights into loss of function of a pore forming toxin and its role in pneumococcal adaptation to an intracellular lifestyle.

Authors:  Dilip C Badgujar; Anjali Anil; Angharad E Green; Manalee Vishnu Surve; Shilpa Madhavan; Alison Beckett; Ian A Prior; Barsa K Godsora; Sanket B Patil; Prachi Kadam More; Shruti Guha Sarkar; Andrea Mitchell; Rinti Banerjee; Prashant S Phale; Timothy J Mitchell; Daniel R Neill; Prasenjit Bhaumik; Anirban Banerjee
Journal:  PLoS Pathog       Date:  2020-11-20       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.